false
Catalog
OPAM Workshop: DOT FMCSA NRCME Course
263074 - Article 8
263074 - Article 8
Back to course
Pdf Summary
The document outlines the guidelines and protocols for managing cardiovascular conditions in commercial motor vehicle drivers, as per the American Osteopathic College of Occupational and Preventive Medicine under FMCSA regulation. <strong>Cardiovascular Risk</strong>: The recommendations are based on the Framingham risk score, which assesses a 20% risk of coronary heart disease (CHD) events over the next 10 years. CHD equivalents include diabetes mellitus and peripheral vascular disease. <strong>Waiting Periods</strong>: Most cardiovascular conditions require a waiting period before drivers can be certified, and if multiple conditions apply, the longest waiting period must be observed. <strong>Exercise Stress Testing</strong>: An acceptable exercise tolerance test (ETT) must exceed 6 METS without ischemic symptoms, show appropriate systolic blood pressure and heart rate responses, and no ventricular dysrhythmias. <strong>Myocardial Infarction and Angina</strong>: Post-MI, drivers can be certified if asymptomatic, tolerating medications, and without ischemic changes on an EKG. Angina certification requires drivers to be asymptomatic, without recent angina pattern change, and have a normal ETT. <strong>Post-Intervention Procedures (PCI and CABG)</strong>: After PCI, drivers must wait one week for certification, while post-CABG requires a three-month waiting period and evidence of a left ventricular ejection fraction (LVEF) ≥ 40%. <strong>Deep Venous Thrombosis (DVT)</strong>: Certification is contingent upon confirmed etiology and effective treatment without residuals. <strong>Aortic Aneurysm</strong>: Depending on the aneurysm's size and symptoms, certification guidelines differ; larger diameters or specialist-recommended surgery disqualify certification. <strong>Atrial Fibrillation and Hypertrophic Cardiomyopathy</strong>: Drivers with atrial fibrillation are assessed using the CHADS2 score and must adhere to antithrombotic treatment guidelines. Hypertrophic cardiomyopathy guidelines highlight no history of cardiac arrest and specific symptom thresholds. <strong>General Guidelines</strong>: Regular follow-ups, imaging stress tests, and consultations with specialists are emphasized for monitoring and ongoing certification. A 40% ejection fraction minimum is noted across conditions, with all requiring annual recertification. These guidelines ensure drivers' cardiovascular health and safety compliance for commercial vehicle operation.
Keywords
cardiovascular conditions
commercial motor vehicle
FMCSA regulation
Framingham risk score
exercise stress testing
myocardial infarction
post-intervention procedures
deep venous thrombosis
aortic aneurysm
atrial fibrillation
×
Please select your language
1
English